NewAmsterdam Phar…
USUSDNewAmsterdam Pharma Company N.V. (US:NAMS) — Biotechnology: Pharmaceutical Preparations. Počet burz, na kterých se obchodují akcie společnosti: 1. Na této stránce — cena a graf, dividendy, největší akcionáři a historie počtu akcií.
O společnosti
- Web
- ir.newamsterdampharma.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sídlo
- NARRDEN, Netherlands
- Generální ředitel
- Michael Harvey Davidson
- Zaměstnanci
- 100
- Akcie v oběhu
- 119.54 mil. k 2026-08-03
- Volně obchodovatelné akcie
- 81.5 mil.
- Tržní kapitalizace
- 2.89 mld. USD
- Insideři
- 0.9%
- Instituce
- 106.61%
- Odvětví (SIC)
- Pharmaceutical Preparations
- FCF
- −144 mil. USD
- Dluh
- 0
- Zisky a FCF — za 12 měsíců do roku 30.06.2026 (nejnovější zpráva společnosti).
Popis
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
Burzy a tickery
| Burza | Ticker | Měna | Cena | Typ |
|---|---|---|---|---|
| US USA Stocks | NAMS | USD | 21.26 -3.93% | kmenové akcie |
Největší držitelé
| Držitel | Podíl | Akcie | Datum zprávy |
|---|---|---|---|
| Frazier Life Sciences Ma… | 15.13% | 18.09 mil. | 2026-06-30 |
| Capital World Investors | 10.23% | 12.23 mil. | 2026-06-30 |
| FMR, LLC | 8.65% | 10.34 mil. | 2026-06-30 |
| RA Capital Management, L… | 7.99% | 9.55 mil. | 2026-06-30 |
| SmallCap World Fund Inc | 7.75% | 9.27 mil. | 2026-06-30 |
| FCPM III Services B.V. | 7.1% | 8.49 mil. | 2026-06-30 |
| Deerfield Management Com… | 3.57% | 4.26 mil. | 2026-06-30 |
| Viking Global Investors,… | 3.52% | 4.2 mil. | 2026-06-30 |
| Bain Capital Life Scienc… | 3.18% | 3.81 mil. | 2026-06-30 |
| Maverick Capital Ltd. | 2.73% | 3.27 mil. | 2026-06-30 |
| Duquesne Family Office L… | 2.57% | 3.07 mil. | 2026-06-30 |
| Fidelity Contrafund | 1.95% | 2.33 mil. | 2026-07-31 |
| Fidelity Rutland Square… | 1.87% | 2.24 mil. | 2026-07-31 |
| DAVIDSON MICHAEL H (Chie… | ≈0.9% | 1.08 mil. | 2026-09-14 |
| New Economy Fund | 0.8% | 957 477 | 2026-06-30 |
| T. Rowe Price Health Sci… | 0.76% | 912 500 | 2026-06-30 |
| Fidelity Select Portfoli… | 0.71% | 847 600 | 2026-07-31 |
| -Capital Group U.S. Smal… | 0.51% | 608 660 | 2026-05-31 |
| iShares Trust-iShares Bi… | 0.5% | 603 124 | 2026-08-31 |
| Prudential Sector Funds,… | 0.45% | 534 102 | 2026-05-31 |
| American Century Mutual… | 0.44% | 524 241 | 2026-07-31 |
| SOMAIYA MAYUR IAN (Chief… | ≈0.05% | 58 382 | 2026-01-21 |
| MARINO MICHAEL F III (Of… | ≈0.05% | 55 000 | 2025-05-30 |
| KLING DOUGLAS F (Chief O… | ≈0.04% | 44 000 | 2025-07-16 |
| JONES WILLIAM A JR (Offi… | ≈0.04% | 43 000 | 2025-01-07 |
| KOOIJ LOUISE FREDERIKA (… | ≈0.02% | 24 353 | 2026-07-20 |
| AUDET JULIETTE BERANGERE… | ≈0.01% | 15 104 | 2025-01-07 |
| FORGROWTH NAP B.V. (Bene… | — | — | 2024-12-30 |
| KASTELEIN JOHANNES JACOB… | — | — | 2026-08-24 |
| TOPPER JAMES N (Director… | — | — | 2025-09-15 |
